2017

1. Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma

   Clinical Cancer Research, Vol. 23, Núm. 21, pp. 6602-6615

2. Preclinical anti-myeloma activity of EDO-S101, a new bendamustine-derived molecule with added HDACi activity, through potent DNA damage induction and impairment of DNA repair

   Journal of Hematology and Oncology, Vol. 10, Núm. 1

3. The kinesin spindle protein inhibitor filanesib enhances the activity of pomalidomide and dexamethasone in multiple myeloma

   Haematologica, Vol. 102, Núm. 12, pp. 2113-2124